News

Researchers from Aston University, Birmingham, UK have developed a potential breakthrough treatment for osteosarcoma, the most common form of bone cancer.

A study on online adaptive radiotherapy reveals reduced treatment margins and lower radiation doses to organs at risk in gastric MALT lymphoma patients

Circadian rhythm disruption has been strongly linked to the development of Type 2 diabetes.

A history of paediatric cancer has been linked to long-term cognitive challenges after treatment, affecting areas such as working memory and processing speed.

A meta-analysis reveals that COVID-19 significantly affects male fertility, reducing sperm concentration, motility, and altering reproductive hormones.

A recent study has found that children with sickle cell disease are at an increased risk of ADHD, with many cases going undiagnosed.

Recent research underscores the long-lasting benefits of early peanut introduction in preventing peanut allergy.

Recent research investigates the effectiveness of sildenafil citrate in reducing fetal distress and emergency caesarean section during labour.

A study has revealed significant differences in influenza and COVID-19 vaccination rates among children receiving long-term ventilation through tracheostomy,

A new study shows that allergy immunotherapy may offer relief for young children with allergic rhinitis while also reducing asthma risks.

A new trial has evaluated and personalised treatments for metastatic castration-resistant prostate cancer, representing a major advancement in treatment options for the disease.

A study comparing pelvic floor yoga and general exercise found both effective in reducing urinary incontinence in women, with no significant difference between the two approaches.

Adding allopurinol to maintenance therapy for paediatric ALL improves outcomes and reduces liver toxicity, even in patients with normal 6-MP metabolism.

A study from Weill Cornell Medicine, New York, USA has revealed a unique pattern of brain activity that may predispose certain individuals to depression.

A groundbreaking clinical trial testing QH104, an allogeneic B7H3-targeting CAR-γδT cell therapy, has shown promising results for patients with recurrent glioblastoma.

A new study provides the first evidence that breastfeeding is safe for women with BRCA mutations after breast cancer treatment.

Results from the phase 3 ENGOT-cx11/GOG-3047/KEYNOTE-A18 study have been presented at ESMO 2024, Barcelona, Spain

The PEACE-3 trial shows that combining Enzalutamide with Radium-223 improves progression-free survival in metastatic castration-resistant prostate cancer.

A study revealed that the severity of Raynaud’s phenomenon, a common early manifestation of systemic sclerosis, is influenced significantly by ambient temperature.

New clinical trial results, presented at ESMO 2024, show that an investigational mRNA-based vaccine CVGBM is safe and well-tolerated in patient with newly diagnosed MGMT-unmethylated glioblastoma (GBM).

Researchers have confirmed that the COVID-19 mRNA vaccination is safe and beneficial for children and adults with sickle cell disease.

The ESC 2024 TIGHT-K trial found that relaxed potassium control is just as effective as tight control for preventing atrial fibrillation post-CABG surgery.

A recent study shows that post-transplant cyclophosphamide-based prophylaxis improves outcomes for hematopoietic cell transplantation patients.

A single-pill with four blood pressure drugs is more effective than a three-drug combo for resistant hypertension, per ESC Congress 2024.